Mesenchymal Stem Cell Therapy for the Treatment of Severe or Refractory Inflammatory and/or Autoimmune Disorders

NCT01540292 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Crohn's Disease

Interventions

BIOLOGICAL: Mesenchymal Stem Cells (MSC)

Sponsor

University of Liege